Skip to main content
. 2017 Jun 20;7:3860. doi: 10.1038/s41598-017-04170-1

Figure 6.

Figure 6

AAV-shRNA treatment improves liver tissue histology without inducing acute inflammation. Mice received AAV2-shRNA treatment, and serum and liver samples were collected at the indicated time points during a 6 month period. (a–c) Time-course changes of serum levels of ALT (a), AST (b), and IL-6 (c). (d) Liver sections stained with hematoxylin and eosin. Data represent the mean ± SD.